Practical resources for Canadian pharmacy owners

Explore pharmacy valuation, sale preparation and succession planning. Read the articles, then use the interactive Resource Centre to prepare your next conversation.

Pharmacy financial figures: gross profit, gross margin, NOI and EBITDA

Understand the numbers behind your pharmacy sale, with a reconciled example from revenue and gross margin to sustainable earnings.

Pharmacy share or asset purchase agreement: what sellers should expect

A seller’s guide to the definitive agreement, from the assets or shares being sold to payment conditions and responsibilities after closing.

Pharmacy sale inventory and working capital: understand the price adjustments

Follow the bridge from the headline business value to the agreed closing price, and avoid counting pharmacy inventory twice.

Pharmacy acquisition financing: how sellers can assess buyer capacity

Understand how experienced groups and individual owners approach funding, and what a seller should verify before relying on an offer.

Selling a pharmacy in Canada: what happens from an accepted offer to closing?

A practical sequence for owners managing diligence, approvals, closing documents and continuity while the pharmacy keeps operating.

What is your pharmacy worth? Start with earnings, then define the price

Build an understandable valuation conversation without treating an online multiple as a market fact.

EBITDA add-backs: what to support, what to challenge and what to subtract

A practical evidence framework for normalization, including owner compensation and missing recurring costs.

Who could buy your pharmacy? Understand experienced groups and individual owners

Explore the preferred buyer segments and prepare for a conversation about appetite, operating fit and transaction-specific capacity.

Reading a letter of intent: follow the money and the conditions

Look beyond the headline price to understand structure, timing, exclusivity and deferred amounts.

Preparing a CIM and data room that buyers can actually use

Tell a coherent business story, make the numbers traceable and control confidential information.

When should you sell? Build readiness before chasing a market window

Separate personal timing, business readiness and uncertain market conditions to create a practical exit plan.

Lease and staffing readiness: can a buyer keep the pharmacy running?

Bring premises security, coverage costs and ownership-change dependencies into the sale discussion early.

Protecting confidentiality during a pharmacy sale

A staged disclosure plan protects the business while giving qualified buyers enough information to investigate.

Due diligence pitfalls that owners can prepare for

Resolve contradictory records, unsupported adjustments and operating dependencies before they surprise a buyer.

Asset sale or share sale? Define the structure before comparing proceeds

Explore the questions behind price, liabilities, inventory, tax and approvals without assuming one structure is always better.

What moves a pharmacy multiple? Value drivers beyond population density

A practical review of the operating strengths and risks that can raise or reduce value, including in smaller markets.

OAT and safer-supply services: patient care, business resilience and Ontario’s October 2026 changes

How a properly supported OAT or clinic service can fit a pharmacy business, and what the October 13 CPSO announcement changes for safer-supply prescribing.

Your 12–24-month pharmacy exit roadmap

A staged preparation plan with clear outputs and decision points. Adapt the timetable to your business and goals.

Pharmacy seller document checklist

An indexed evidence list for preparation and controlled diligence, with sensitive records kept out of public forms.

Questions to ask buyers and advisors before committing to a sale

A practical conversation guide to reveal funding, deal structure, operating plans and advisory responsibilities.

Plan your next conversation

Smith & Bederman Advisory Group supports independent Canadian pharmacy owners with sales, acquisitions, valuation and succession planning.

Explore valuation and EBITDA tools · Check exit readiness · Book a confidential consultation

Calculator access, full buyer profiles and downloads are available through the Resource Centre’s access form.